Esophageal Cancer

Contact: CancerResearch@VirginiaMason.org or (206) 342-6954

Clinical StudiesDiagnosis
Non-MetastaticMetastaticPreviously TreatedTreatment Naive

An Investigational Immuno-therapy Study of Nivolumab or Placebo in Patients With Resected Esophageal or Gastroesophageal Junction Cancer

 ✔✔ 

Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

 ✔ ✔
VM BRITE: A Tissue Registry and Specimen Repository to Support Future Research Projects✔✔✔✔